Caseware UK (AP4) 2024.0.164 2024.0.164 2025-03-312025-03-31falseNo description of principal activity22024-04-01false2falseThe members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006. SC768905 2024-04-01 2025-03-31 SC768905 2023-05-10 2024-03-31 SC768905 2025-03-31 SC768905 2024-03-31 SC768905 c:Director1 2024-04-01 2025-03-31 SC768905 d:CurrentFinancialInstruments 2025-03-31 SC768905 d:CurrentFinancialInstruments 2024-03-31 SC768905 c:Micro-entities 2024-04-01 2025-03-31 SC768905 c:AuditExempt-NoAccountantsReport 2024-04-01 2025-03-31 SC768905 c:FullAccounts 2024-04-01 2025-03-31 SC768905 c:PrivateLimitedCompanyLtd 2024-04-01 2025-03-31 SC768905 e:PoundSterling 2024-04-01 2025-03-31 iso4217:GBP xbrli:pure

Registered number: SC768905










CROSS MEDICAL LIMITED








UNAUDITED

FINANCIAL STATEMENTS

INFORMATION FOR FILING WITH THE REGISTRAR

FOR THE YEAR ENDED 31 MARCH 2025

 
CROSS MEDICAL LIMITED
REGISTERED NUMBER: SC768905

BALANCE SHEET
AS AT 31 MARCH 2025

2025
2024
£
£


Fixed assets
250
417

Current assets
8,505
6,901

Creditors: amounts falling due within one year
(9,040)
(7,720)

Net current liabilities
 
 
(535)
 
 
(819)

Total assets less current liabilities
(285)
(402)


Net liabilities
(285)
(402)



Capital and reserves
(285)
(402)


Notes


General information

Cross Medical Limited in a private company limited by shares incorporated in Scotland. The registered office address is 6 St Colme Street, Edinburgh, EH3 6AD.


Average number of employees

The average monthly number of employees, including directors, during the year was 2 (2024 - 2).

The directors consider that the Company is entitled to exemption from audit under section 477 of the Companies Act 2006 and members have not required the Company to obtain an audit for the year in question in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

These financial statements have been prepared in accordance with the provisions applicable to entities subject to the micro-entities' regime.

The financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The financial statements were approved and authorised for issue by the board and were signed on its behalf on 10 December 2025.




Dr S Strachan
Director

 
Page 1